EPHX2 and hypertensive disorder: Pharmacological inhibition of the hydrolase activity and genetic disruption of sEH both can increase the accumulation of EETs and other epoxy fatty acids which attenuate angiotensin II-induced hypertension and cardiac hypertrophy and fibrosis [9, 10].